NCT07337447 2026-01-13
REWENEC 01
Hospices Civils de Lyon
Phase 2 Not yet recruiting
Clinical Trials
3 trialsNCT07156019 2025-09-04
Sintilimab in Combination With Surufatinib and Temozolomide in the Advanced Neuroendocrine Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
NCT06816394 2025-02-10
TAURUS
National Taiwan University Hospital
Phase 2 Not yet recruiting